Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma?

US Neurology - United Kingdom
doi 10.17925/usn.2014.10.01.48
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.


Related search